Skip to main content

Table 3 Postoperative variables

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 Terlipressin group (n = 50)Placebo group (n = 50)P value
NEPt (n)215< 0.001*
Dose (μg.kg−1.min−1)0 ± 0.0090.03 ± 0.042< 0.001*
EPt (n)19210.683
Dose (μg.kg−1.min−1)0.04 ± 0.050.05 ± 0.0510.723
Inotropic score3 (0–9)7 (3–11)0.014*
Vasopressor dependency index0.06 ± 0.0650.1 ± 0.0740.012*
  1. n number of patients, NE norepinephrine, E epinephrine
  2. Mean ± SD
  3. P value is significant when P < 0.05